Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cancer Recurrent 1Neoplasm Metastasis 1Melanoma 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 22Trastuzumab 16Paclitaxel 15Radiotherapy 13Docetaxel 13Capecitabine 11Doxorubicin 10Taxes 9Lapatinib 9Carboplatin 8Tamoxifen 7Immunohistochemistry 7Biopsy 7Albumin-Bound Paclitaxel 7Magnetic Resonance Spectroscopy 6Fluorodeoxyglucose F18 6Chemotherapy, Adjuvant 6Immunoenzyme Techniques 5Gemcitabine 5Flow Cytometry 5Bevacizumab 5sargramostim 4Vinorelbine 4Letrozole 4Irinotecan 4Granulocyte-Macrophage Colony-Stimulating Factor 4Filgrastim 4Everolimus 4Erlotinib Hydrochloride 4Cisplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms, Male × poly(I).poly(c12,U) × Clear all
NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

University of Washington

Phase 1/2 Completed
50 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡